| Developing an international network for Alzheimer’s research: the Dominantly Inherited Alzheimer Network Clinical Investigation 2 (10), 975–984, 2012 | 216 | 2012 |
| Clinical outcome measures for trials in Duchenne muscular dystrophy: report from International Working Group meetings K Bushby, E Connor Clinical investigation 1 (9), 1217, 2011 | 173 | 2011 |
| Data fraud in clinical trials SL George, M Buyse Clinical investigation 5 (2), 161, 2015 | 137 | 2015 |
| Cyclosporine ophthalmic emulsions for the treatment of dry eye: a review of the clinical evidence P Ames, A Galor Clinical investigation 5 (3), 267, 2015 | 91 | 2015 |
| Outcome measures in amyotrophic lateral sclerosis clinical trials S Paganoni, M Cudkowicz, JD Berry Clinical investigation 4 (7), 605, 2014 | 66 | 2014 |
| Novel oral taxane therapies: recent Phase I results JP Flores, MW Saif Clinical investigation 3 (4), 333, 2013 | 66 | 2013 |
| Identifying and prioritizing unmet research questions for people with tinnitus: The James Lind Alliance Tinnitus Priority Setting Partnership. DA Hall, N Mohamad, L Firkins, M Fenton, D Stockdale | 60 | 2013 |
| Novel agents in Waldenström macroglobulinemia GC Issa, IM Ghobrial, AM Roccaro Clinical investigation 1 (6), 815, 2011 | 58 | 2011 |
| Proximate composition, mineral and some vitamin contents of tigernut (Cyperus esculentus) MS Suleiman, JE Olajide, JA Omale, OC Abbah, DO Ejembi Clinical Investigation 8 (4), 161-165, 2018 | 47 | 2018 |
| New considerations in the design of clinical trials for amyotrophic lateral sclerosis JD Berry, ME Cudkowicz Clinical investigation 1 (10), 1375, 2011 | 46 | 2011 |
| New considerations in the design of clinical trials for traumatic brain injury B Roozenbeek, HF Lingsma, AIR Maas Clinical investigation 2 (2), 153, 2012 | 45 | 2012 |
| Encouraging young men's participation in mental health research and treatment: perspectives in our technological age LA Ellis, KL McCabe, KA Rahilly, MA Nicholas, TA Davenport, JM Burns, ... Clin Investig 4 (10), 881-888, 2014 | 44 | 2014 |
| Geographic distribution of clinical trials may lead to inequities in access EM Seidler, A Keshaviah, C Brown, E Wood, L Granick, AB Kimball Clin Invest 4 (4), 373-380, 2014 | 43 | 2014 |
| Androgen receptor and immune inflammation in benign prostatic hyperplasia and prostate cancer K Izumi, L Li, C Chang Clinical investigation 4 (10), 935, 2014 | 42 | 2014 |
| Research involving pregnant women: trials and tribulations. F Baylis, SA Halperin | 40 | 2012 |
| Outcome measures for clinical trials assessing treatment of cystic fibrosis lung disease DR VanDevanter, MW Konstan Clinical investigation 2 (2), 163, 2012 | 40 | 2012 |
| Velaglucerase alfa in the treatment of Gaucher disease type 1 TA Burrow, GA Grabowski Clinical investigation 1 (2), 285, 2011 | 39 | 2011 |
| Prosthetic valve endocarditis: state of the heart. AN Avish Nagpal, MR Sohail, JM Steckelberg | 37 | 2012 |
| Multi-arm clinical trials with treatment selection: what can be gained and at what price? T Jaki Clinical Investigation 5 (4), 393-399, 2015 | 34 | 2015 |
| When should the sequential parallel comparison design be used in clinical trials? L Baer, A Ivanova | 34 | 2013 |
